Cargando…

Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets

Motor neuron diseases (MNDs) are a group of fatal, neurodegenerative disorders with different etiology, clinical course and presentation, caused by the loss of upper and lower motor neurons (MNs). MNs are highly specialized cells equipped with long, axonal processes; axonal defects are some of the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagliardi, Delia, Pagliari, Elisa, Meneri, Megi, Melzi, Valentina, Rizzo, Federica, Comi, Giacomo Pietro, Corti, Stefania, Taiana, Michela, Nizzardo, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945549/ https://www.ncbi.nlm.nih.gov/pubmed/35327513 http://dx.doi.org/10.3390/biomedicines10030711

Ejemplares similares

Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
por: Rizzuti, Mafalda, et al.
Publicado: (2022)

Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

New Insights into Cerebral Vessel Disease Landscapes at Single-Cell Resolution: Pathogenetic and Therapeutic Perspectives
por: Meneri, Megi, et al.
Publicado: (2022)

Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross‐sectional study
por: Gagliardi, Delia, et al.
Publicado: (2021)

Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
por: Rizzo, Federica, et al.
Publicado: (2019)

Homozygous SOD1 Variation L144S Produces a Severe Form of Amyotrophic Lateral Sclerosis in an Iranian Family
por: Gagliardi, Delia, et al.
Publicado: (2021)

Synaptotagmin 13 is neuroprotective across motor neuron diseases
por: Nizzardo, M., et al.
Publicado: (2020)

NOTCH2NLC GGC repeats are not expanded in Italian amyotrophic lateral sclerosis patients
por: Manini, Arianna, et al.
Publicado: (2023)

MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
por: Rizzuti, Mafalda, et al.
Publicado: (2018)

Analysis of HTT CAG repeat expansion in Italian patients with amyotrophic lateral sclerosis
por: Manini, Arianna, et al.
Publicado: (2022)

Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown–Vialetto disease that is partially rescued by riboflavin
por: Rizzo, Federica, et al.
Publicado: (2017)

Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
por: Contardo, Matilde, et al.
Publicado: (2022)

Newly Diagnosed Hepatic Encephalopathy Presenting as Non-convulsive Status Epilepticus: A Case Report and Literature Review
por: Olivero, Marco, et al.
Publicado: (2022)

Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)

Clinical and molecular features of patients with amyotrophic lateral sclerosis and SOD1 mutations: a monocentric study
por: Gagliardi, Delia, et al.
Publicado: (2023)

Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
por: Meneri, Megi, et al.
Publicado: (2023)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
por: Costamagna, Gianluca, et al.
Publicado: (2020)

Ischemic optic neuropathy as first presentation in patient with m.3243 A > G MELAS classic mutation
por: Scarcella, Simone, et al.
Publicado: (2023)

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches
por: Nizzardo, Monica, et al.
Publicado: (2015)

Expanding the clinical spectrum of the mitochondrial mutation A13084T in the ND5 gene
por: Brusa, Roberta, et al.
Publicado: (2020)

Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018)

Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020)

Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
por: Gagliardi, Delia, et al.
Publicado: (2020)

The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2023)

Impact of COVID‐19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
por: Gagliardi, Delia, et al.
Publicado: (2021)

Advancing Stroke Research on Cerebral Thrombi with Omic Technologies
por: Costamagna, Gianluca, et al.
Publicado: (2023)

Neural Stem Cell Transplantation for Neurodegenerative Diseases
por: De Gioia, Roberta, et al.
Publicado: (2020)

Unraveling the Neurological Complexity of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes Syndrome: A Report of a Challenging Case of a Young Woman and Cutting-Edge Advancements in the Field
por: Furciniti, Gioconda, et al.
Publicado: (2023)

Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022)

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot–Marie–Tooth type 2A
por: Rizzo, Federica, et al.
Publicado: (2023)

Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature
por: Gagliardi, Delia, et al.
Publicado: (2019)

Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
por: Bersani, Margherita, et al.
Publicado: (2022)

Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study
por: Faravelli, Irene, et al.
Publicado: (2023)

Case Report: Rare Homozygous RNASEH1 Mutations Associated With Adult-Onset Mitochondrial Encephalomyopathy and Multiple Mitochondrial DNA Deletions
por: Manini, Arianna, et al.
Publicado: (2022)

Charcot–Marie–Tooth disease type 2F associated with biallelic HSPB1 mutations
por: Abati, Elena, et al.
Publicado: (2021)

MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
por: Gagliardi, Delia, et al.
Publicado: (2019)

iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
por: Simone, Chiara, et al.
Publicado: (2014)

Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012)

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model
por: Nizzardo, Monica, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_biaf45k79muo8q6m39j6eha3kn